Schedule 13G ownership disclosure

Amneal Pharmaceuticals Inc

Security class unavailable · CUSIP: 03168L105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,406,795
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000834237-21-003001
Form type
SC 13G/A
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Jan 29, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub